These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 38282090)
1. Tumor-derived extracellular vesicles: how they mediate glioma immunosuppression. Ma T; Su G; Wu Q; Shen M; Feng X; Zhang Z Mol Biol Rep; 2024 Jan; 51(1):235. PubMed ID: 38282090 [TBL] [Abstract][Full Text] [Related]
2. Immune microenvironment of gliomas. Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634 [TBL] [Abstract][Full Text] [Related]
3. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment. Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle. Wurdinger T; Deumelandt K; van der Vliet HJ; Wesseling P; de Gruijl TD Biochim Biophys Acta; 2014 Dec; 1846(2):560-75. PubMed ID: 25453365 [TBL] [Abstract][Full Text] [Related]
6. New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs. Lakshmanachetty S; Cruz-Cruz J; Hoffmeyer E; Cole AP; Mitra SS Cells; 2021 Apr; 10(4):. PubMed ID: 33919732 [TBL] [Abstract][Full Text] [Related]
8. Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression. Li L; You W; Wang X; Zou Y; Yao H; Lan H; Lin X; Zhang Q; Chen B Phytomedicine; 2023 Jan; 108():154508. PubMed ID: 36332384 [TBL] [Abstract][Full Text] [Related]
9. Systemic and local immunosuppression in glioblastoma and its prognostic significance. Stepanenko AA; Sosnovtseva AO; Valikhov MP; Chernysheva AA; Abramova OV; Pavlov KA; Chekhonin VP Front Immunol; 2024; 15():1326753. PubMed ID: 38481999 [TBL] [Abstract][Full Text] [Related]